Qualcomm's interest in acquiring Intel has cooled, Bloomberg News reports-March 2024-www.financetom.com

Qualcomm's interest in acquiring Intel has cooled, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Qualcomm's interest in acquiring Intel has cooled, Bloomberg News reports

Nov 25, 2024 6:42 PM

Nov 25 (Reuters) - Qualcomm's ( QCOM ) interest in

acquiring chipmaker Intel ( INTC ) is said to have cooled,

Bloomberg News reported on Monday, citing people familiar with

the matter.

(Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Varun H

Previous page： Explained: Why tech giants are making customised chips Next page： Explained: Apple’s strategy to fight off antitrust regulators

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Explained: Why tech giants are making customised chips

Sep 7, 2021

The global chip shortage is a key factor behind this move. Further, the likes of Apple, Tesla and Google are finding it more cost-effective to integrate their software with their in-house semiconductors instead of using the generic chips available to all.

Explained: Apple’s strategy to fight off antitrust regulators

Sep 6, 2021

Apple has implemented major changes to its app store after seeing investigations, lawsuits and anti-trust legislation pile up in several countries against its practices.

Zen Technologies eyes new orders for drone, simulator verticals; expects Rs 550 cr revenue in 3 years

Sep 6, 2021

The Zen Technologies stock has been busting the charts. It has gained over 75 percent in the last seven trading...

From Silicon Valley darling to fraud accused, the rise and fall of Theranos founder Elizabeth Holmes

Sep 8, 2021

The “youngest woman entrepreneur and a billionaire” Elizabeth Anne Holmes, the founder of failed biotech start-up Theranos, is facing up to 20 years in jail for a dozen of wire frauds.